Investor Alert: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. And Encourages Investors To Contact The Firm Before The Deadline

IRVINE, Calif.–(BUSINESS WIRE)–Khang & Khang LLP (the “Firm”) announces that a class action lawsuit has been filed against Esperion Therapeutics, Inc. (“Esperion” or the “Company”) (Nasdaq: ESPR). Investors who purchased or otherwise acquired shares between August 18, 2015 and September 28, 2015, inclusive (the “Class Period”) are encouraged to contact the Firm prior to the March 14, 2016 lead plaintiff motion deadline. If you purchased shares of Esperion during the Class Period, please c
Source: BusinessWire-Primary

Investor Alert: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Esperion Therapeutics, Inc. And Encourages Investors To Contact The Firm Before The Deadline